- Credit Type: CME
- Credit Amount: 2.00
- Cost: Free
- Release: Mar 27, 2015
- Expires: Sep 12, 2017
- Estimated Time to Complete:
- System Requirements:
Average User Rating:
Professor and Chair, Eugene and Marilyn Glick Eye Institute
Professor of Ophthalmology and Cell Biology
Co-Director of the Glaucoma Service
Department of Ophthalmology
SUNY Downstate Medical Center
Needs StatementThere are multiple avenues of investigation into the molecular mechanisms of glaucoma and treatment strategies to halt the progression of this blinding disease. In this translational mini-symposium event, we aim to provide a unique cross-section of the field with insights into new findings and approaches to management of glaucoma.
Target AudiencePhysicians, clinical researchers, optometry students, residents, fellows and any healthcare professional interested in ophthamology
ObjectivesUpon completion of this activity participants will be able to:
1. Discuss pathogenesis mechanisms adn disease progression of glaucoma
2. Discuss updates on treatment management strategies of glaucoma
The University of Kentucky College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Kentucky College of Medicine designates this enduring material for a maximum of 2.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.
- Patient care
- Medical knowledge
Faculty DisclosureLouis B. Cantor, MD (speaker) has relevant financial relationships with commercial interests as follows: Allergan - Investigator - Research support; Glaukos - Invetigator - Research support; InnFocus - Investigaor - Research Support; Aerie - Consultant - Consultant Fee; Mati - Investor/Consultant - Ownership Interest; Bausch and Lomb - Investigator - Research Support
John Danias, MD, PhD (speaker) has no relevant financial relationships with commercial interests.
No (other) speakers, planners or content reviewers have any relevant financial relationships to disclose.
The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.
Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.